XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer CellsNatalia Pajuelo‐Lozano(Universidad Autónoma de Madrid), Isabel Sánchez‐Pérez(Instituto de Investigaciones Biomédicas Sols-Morreale)Frontiers in PharmacologyOctober 17, 201810.3389/fphar.2018.01197Cited by 29SaveCiteExport RISWatch citationsRelated PapersTargeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines|Theranostics|2020|46